THURSDAY, Dec. 6, 2018 -- Medical science has made tremendous advances in "personalized medicine" -- drugs that fight cancer and other diseases by boosting the immune system or targeting specific genetic traits.
Former U.S. President Jimmy Carter benefited from one of these drugs, Keytruda (pembrolizumab), which successfully beat back his brain cancer by ramping up his immune system.
THURSDAY, Dec. 6, 2018 -- Cases of uterine cancer are charting a slow but steady rise among American women, and so are deaths from the disease, new statistics show.
Looking at federal health data, researchers from the U.S. Centers for Disease Control and Prevention found that "during 1999-2015, uterine cancer incidence rates increased 12 percent, about 0.7 percent per year, on average."
WEDNESDAY, Oct. 24, 2018 -- Millions of Americans take angiotensin-converting enzyme (ACE) inhibitors to lower their blood pressure, but a new study suggests they might also increase their odds of developing lung cancer.
Among people taking these drugs for more than five years, the increased risk may be as high as 14 percent. Although that seems a small number, it could represent a large number of patients, the study authors noted.